Fundraising Fox
/People
Sign in

Christian R. Schubert

Investor

Vice President and Global Head of AbbVie Ventures at AbbVie

Cambridge, Massachusetts, United States

Find your path to Christian

1,350 people in our graph can introduce you to Christian.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jamie Bacher to introduce you to Christian

You →Jamie · together at Bakar Bio Labs (2023–2026) →Christian

Ask Jamie Chen to introduce you to Christian

You →Jamie · together at BioMotiv →Christian

Ask Sam Okafor to introduce you to Christian

You →Sam · together at Soufflé Therapeutics →Christian

Sign up to find every way you can get introduced to Christian

  • Your email: the people you already email who know Christian
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Christian
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Christian Schubert is a hybrid operator-investor who shapes corporate venture strategy across US, Europe and Asia‑Pacific, pairing genetics, neurobiology and biochemistry training with large‑pharma experience and active biotech board involvement.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtech

Experience

  1. AbbVieVice President and Global Head, AbbVie Venturescurrent2022 — presentCambridge, MA
  2. Mozart Therapeutics, IncMember | Board of Directorscurrent2023 — presentSeattle, Washington, United States
  3. Zag BioMember | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
  4. DISCO Pharmaceuticals GmbHMember | Board of Directorscurrent2023 — presentCologne, North Rhine-Westphalia, Germany
  5. ReAx BiotechnologiesMember | Board of Directorscurrent2023 — presentChicago, Illinois, United States
  6. Dimericon TherapeuticsMember | Board of Directorscurrent2023 — presentZurich, Switzerland
  7. Soufflé TherapeuticsObserver | Board of Directorscurrent2024 — presentWatertown, Massachusetts, United States
  8. Umoja BiopharmaObserver | Board of Directorscurrent2023 — presentSeattle, WA
  9. Aquinnah PharmaceuticalsObserver | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
  10. Blackbird LaboratoriesAdvisory Board Membercurrent2025 — present
  11. Alexandria LaunchLabsAdvisor | Seed Capital Platformcurrent2023 — present
  12. Bakar Bio LabsAdvisor | Bakar Bio Labscurrent2023 — present
  13. DG MedicinesObserver | Board of Directors2023 — 2025Boston, Massachusetts, United States
  14. Enthera PharmaceuticalsMember | Board of Directors2023 — 2024Milan, Lombardy, Italy
  15. Enthera PharmaceuticalsObserver | Board of Directors2023Milan, Lombardy, Italy
  16. Ribometrix Inc.Member | Board of Directors2023 — 2024Durham, North Carolina, United States
  17. Portera TherapeuticsMember | Board of Directors2023 — 2024East Lansing, Michigan, United States
  18. Ambagon TherapeuticsMember | Board of Directors2023 — 2024San Francisco, California, United States
  19. SNC Therapeutics, Inc.Member | Board of Directors2023 — 2024Chicago, Illinois, United States
  20. Ribon TherapeuticsObserver | Board of Directors2023 — 2024Cambridge, Massachusetts, United States
  21. Accent Therapeutics, Inc.Observer | Board of Directors2023 — 2024Lexington, Massachusetts, United States
  22. Quanta TherapeuticsObserver | Board of Directors2023 — 2024San Francisco, California, United States
  23. Kojin TherapeuticsObserver | Board of Directors2023 — 2024Boston, Massachusetts, United States
  24. Caraway Therapeutics, Inc.Member | Board of Directors2023Cambridge, Massachusetts, United States
  25. Atlas VentureCo-Founder and Advisor, Modify Therapeutics2022Cambridge, Massachusetts, United States
  26. Atlas VentureCo-Founder and President, Modify Therapeutics2022Cambridge, MA
  27. Atlas VentureEntrepreneur In Residence (EIR)2021 — 2022Cambridge, Massachusetts, United States
  28. Korro Bio, Inc.Advisor | CNS Biology, Neuroscience Strategy and Operations2021 — 2022Cambridge, Massachusetts, United States
  29. ServierGlobal Head, External Innovation | Research and Development2018 — 2021Paris Area, France
  30. ServierManaging Director | Servier BioInnovation2018 — 2021Cambridge, Massachusetts, United States
  31. BioMotivAdvisory Board Member2016 — 2019Cleveland, Ohio
  32. Israel Biotech FundStrategic Advisor2016 — 2018Rehovot, Israel
  33. BiogenDirector | Corporate Strategy, Business Development and External Innovation2015 — 2018Cambridge, Massachusetts
  34. Harvard UniversityHead Teaching Fellow | MCB 80 - Neurobiology of Behavior2010 — 2017Cambridge, Massachusetts
  35. Harvard UniversitySenior Teaching Fellow | Life Sciences 1b - Genetics, Genomics and Evolution2011 — 2016Cambridge, Massachusetts
  36. Harvard UniversityHead Writer and Content Developer | HarvardX | Fundamentals of Neuroscience (mcb80x)2013 — 2015Cambridge, Massachusetts
  37. PfizerAssociate Director | Precision Medicine, Human Genetics and Computational Biomedicine2012 — 2015Cambridge, Massachusetts
  38. Broad Institute of MIT and HarvardVisiting Postdoctoral Scholar | Medical and Population Genetics2010 — 2014Cambridge, Massachusetts
  39. Boston Children's HospitalRuth L. Kirschstein NIH Postdoctoral Research Fellow | Pediatrics2010 — 2013Boston, Massachusetts
  40. Massachusetts Institute of TechnologyVisiting Scholar and Research Affiliate | Research Laboratory of Electronics2009 — 2012Cambridge, Massachusetts

Skills & more

Neuroscience14Drug Discovery21Biochemistry19Life Sciences12Biotechnology9Genetics25Molecular Biology1Genomics2Clinical Development6ResearchClinical Trials1Confocal Microscopy1
+2 moreCell BiologyClinical Research

Languages English · French · German · Swedish

From Christian's professional profile.

Colleagues at AbbVie

Anke Reichardt
Investor at AbbVie
Azurii Collier
Commercial Advisor at 2Flo Ventures
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
John Ballew
Senior Associate at JDRF T1D Fund

Frequently asked questions

Who is Christian R. Schubert?
Christian Schubert is a hybrid operator-investor who shapes corporate venture strategy across US, Europe and Asia‑Pacific, pairing genetics, neurobiology and biochemistry training with large‑pharma experience and active biotech board involvement.
Where does Christian R. Schubert work?
Christian R. Schubert is Vice President and Global Head of AbbVie Ventures at AbbVie.
What does Christian R. Schubert invest in?
Christian R. Schubert invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
Where did Christian R. Schubert go to school?
Christian R. Schubert studied at Harvard Medical School (Postdoctoral Fellowship (Boston Children's Hospital), Neuroscience); Massachusetts Institute of Technology (Doctor of Philosophy (Ph.D.), Biological Chemistry); Harvard University (Certificate, Introduction to Clinical Investigation).

Same school

Shared employers